Paulson & Co. - Q2 2017 holdings

$7.4 Billion is the total value of Paulson & Co.'s 110 reported holdings in Q2 2017. The portfolio turnover from Q1 2017 to Q2 2017 was 50.5% .

 Value Shares↓ Weighting
AGN SellALLERGAN PLC$657,211,000
-6.5%
2,703,570
-8.1%
8.88%
-4.8%
MYL SellMYLAN N V$618,542,000
-8.2%
15,933,600
-7.8%
8.36%
-6.5%
SHPG SellSHIRE PLCsponsored adr$575,404,000
-17.4%
3,481,600
-12.9%
7.78%
-15.9%
GLD  SPDR GOLD TRUST$514,534,000
-0.6%
4,359,7220.0%6.96%
+1.3%
VRX BuyVALEANT PHARMACEUTICALS INTL$377,372,000
+76.5%
21,813,400
+12.5%
5.10%
+79.8%
TMUS BuyT MOBILE US INC$366,793,000
+37.2%
6,050,700
+46.1%
4.96%
+39.7%
MNKKQ SellMALLINCKRODT PUB LTD CO$308,802,000
-7.6%
6,891,372
-8.1%
4.18%
-5.9%
TWX SellTIME WARNER INC$299,870,000
+1.5%
2,986,455
-1.2%
4.05%
+3.4%
AIG SellAMERICAN INTL GROUP INC$258,881,000
-8.8%
4,140,763
-9.0%
3.50%
-7.1%
DISH BuyDISH NETWORK CORPcl a$250,965,000
+14.6%
3,998,800
+15.9%
3.39%
+16.7%
CACQ  CAESARS ACQUISITION COcl a$249,898,000
+23.7%
13,117,9980.0%3.38%
+26.0%
TEVA SellTEVA PHARMACEUTICAL INDS LTDsponsored adr$224,036,000
-36.5%
6,744,000
-38.7%
3.03%
-35.3%
VST NewVISTRA ENERGY CORP$193,598,00011,530,556
+100.0%
2.62%
CZR  CAESARS ENTMT CORP$173,015,000
+25.7%
14,417,9000.0%2.34%
+28.0%
AABA NewALTABA INC$145,734,0002,675,000
+100.0%
1.97%
NXPI BuyNXP SEMICONDUCTORS N V$131,413,000
+12.1%
1,200,664
+6.0%
1.78%
+14.3%
RLGY SellREALOGY HLDGS CORP$129,800,000
-8.9%
4,000,000
-16.4%
1.76%
-7.2%
AU  ANGLOGOLD ASHANTI LTDsponsored adr$124,245,000
-9.7%
12,782,4000.0%1.68%
-8.0%
SGYPQ  SYNERGY PHARMACEUTICALS DEL$107,195,000
-4.5%
24,088,6550.0%1.45%
-2.8%
NG SellNOVAGOLD RES INC$100,288,000
-6.9%
21,992,896
-0.6%
1.36%
-5.2%
VWR NewVWR CORP$88,308,0002,675,200
+100.0%
1.19%
TSU SellTIM PARTICIPACOES S Asponsored adr$82,149,000
-8.4%
5,550,600
-1.1%
1.11%
-6.6%
WLH  LYON WILLIAM HOMEScl a new$80,209,000
+17.1%
3,322,6660.0%1.08%
+19.3%
ENDP SellENDO INTL PLC$80,139,000
-8.4%
7,174,490
-8.5%
1.08%
-6.7%
BACWSA  BANK AMER CORP* w exp 01/16/2019$75,413,000
+6.5%
6,263,5260.0%1.02%
+8.6%
INSW SellINTERNATIONAL SEAWAYS INC$74,908,000
+6.7%
3,456,773
-5.9%
1.01%
+8.7%
BKD SellBROOKDALE SR LIVING INC$73,350,000
+8.3%
4,986,400
-1.1%
0.99%
+10.3%
ODP SellOFFICE DEPOT INC$71,086,000
+6.8%
12,603,900
-11.6%
0.96%
+8.8%
HZNP NewHORIZON PHARMA PLC$58,584,0004,935,500
+100.0%
0.79%
LOXO SellLOXO ONCOLOGY INC$55,082,000
+61.1%
686,893
-15.5%
0.74%
+64.1%
 COBALT INTL ENERGY INCnote 3.125% 5/15/2024$43,846,000
-20.0%
219,229,0000.0%0.59%
-18.4%
OASPQ SellOASIS PETE INC NEW$39,186,000
-46.7%
4,867,847
-5.6%
0.53%
-45.7%
GOLD  RANDGOLD RES LTDadr$38,188,000
+1.4%
431,7000.0%0.52%
+3.2%
STAY SellEXTENDED STAY AMER INCunit 99/99/9999b$34,938,000
-89.0%
1,804,652
-91.0%
0.47%
-88.8%
AEM  AGNICO EAGLE MINES LTD$34,183,000
+6.3%
757,6000.0%0.46%
+8.2%
ENZY  ENZYMOTEC LTD$34,068,000
-8.0%
4,205,9800.0%0.46%
-6.1%
HTZGQ NewHERTZ GLOBAL HLDGS INCput$29,325,0002,550,000
+100.0%
0.40%
THM  INTERNATIONAL TOWER HILL MIN$26,634,000
-8.6%
55,487,8420.0%0.36%
-7.0%
XCRA NewXCERRA CORP$24,655,0002,523,571
+100.0%
0.33%
ALXN  ALEXION PHARMACEUTICALS INCcall$24,334,000
+0.4%
200,0000.0%0.33%
+2.2%
FB SellFACEBOOK INCcl a$21,817,000
-17.1%
144,500
-22.0%
0.30%
-15.5%
SHPG SellSHIRE PLCcall$20,659,000
-8.8%
125,000
-3.8%
0.28%
-7.3%
L100PS SellARCONIC INC$20,328,000
-21.5%
897,500
-8.7%
0.28%
-20.1%
IAG  IAMGOLD CORP$19,938,000
+29.0%
3,863,9120.0%0.27%
+31.7%
MON BuyMONSANTO CO NEW$18,843,000
+368.8%
159,200
+348.5%
0.26%
+381.1%
MBBYF BuyMOBILEYE N V AMSTELVEEN$17,121,000
+266.9%
272,629
+258.7%
0.23%
+272.6%
FDX BuyFEDEX CORP$16,387,000
+69.6%
75,400
+52.3%
0.22%
+73.4%
XENT SellINTERSECT ENT INC$15,596,000
+42.1%
558,000
-12.8%
0.21%
+44.5%
RAI BuyREYNOLDS AMERICAN INC$15,401,000
+93.9%
236,787
+87.9%
0.21%
+98.1%
NEWR NewNEW RELIC INC$15,195,000353,300
+100.0%
0.20%
TEAM BuyATLASSIAN CORP PLCcl a$13,998,000
+196.9%
397,900
+152.8%
0.19%
+200.0%
DOVA NewDOVA PHARMACEUTICALS INC$13,856,000621,632
+100.0%
0.19%
DXCM SellDEXCOM INC$13,416,000
-34.2%
183,400
-23.8%
0.18%
-33.2%
BCR NewBARD C R INC$13,315,00042,122
+100.0%
0.18%
TIME SellTIME INC NEW$12,731,000
-33.0%
887,200
-9.6%
0.17%
-31.7%
ALXN SellALEXION PHARMACEUTICALS INC$12,556,000
-69.0%
103,200
-69.1%
0.17%
-68.4%
GSK SellGLAXOSMITHKLINE PLCsponsored adr$12,483,000
-28.7%
289,500
-30.3%
0.17%
-27.2%
SD  SANDRIDGE ENERGY INC$11,471,000
-6.9%
666,5350.0%0.16%
-5.5%
TGNA NewTEGNA INC$11,215,000778,300
+100.0%
0.15%
STE SellSTERIS PLC$10,717,000
-63.6%
131,500
-68.9%
0.14%
-62.8%
PANW SellPALO ALTO NETWORKS INC$10,718,000
-38.9%
80,100
-48.6%
0.14%
-37.8%
SNAP  SNAP INCput$10,307,000
-21.1%
580,0000.0%0.14%
-19.7%
ESPR SellESPERION THERAPEUTICS INC NE$9,742,000
+19.0%
210,500
-9.2%
0.13%
+21.1%
ISRG BuyINTUITIVE SURGICAL INC$9,541,000
+68.2%
10,200
+37.8%
0.13%
+72.0%
CTRP NewCTRIP COM INTL LTD$9,329,000173,200
+100.0%
0.13%
SPNC NewSPECTRANETICS CORP$9,120,000237,500
+100.0%
0.12%
Z SellZILLOW GROUP INCcl c cap stk$7,842,000
+39.9%
160,000
-3.9%
0.11%
+43.2%
HCA NewHCA HEALTHCARE INC$7,848,00090,000
+100.0%
0.11%
MYL  MYLAN N Vcall$7,764,000
-0.4%
200,0000.0%0.10%
+1.0%
MGI NewMONEYGRAM INTL INC$7,520,000435,932
+100.0%
0.10%
SA NewSEABRIDGE GOLD INC$7,560,000700,000
+100.0%
0.10%
AMZN BuyAMAZON COM INC$7,550,000
+54.8%
7,800
+41.8%
0.10%
+56.9%
TMQ SellTRILOGY METALS INC NEW$7,338,000
+15.2%
11,566,126
-0.2%
0.10%
+16.5%
BACWSB  BANK AMER CORP* w exp 10/28/2018$7,053,000
-13.9%
8,928,3440.0%0.10%
-12.8%
SERV BuySERVICEMASTER GLOBAL HLDGS I$6,819,000
+43.3%
174,000
+52.6%
0.09%
+46.0%
AMRI NewALBANY MOLECULAR RESH INC$6,818,000314,200
+100.0%
0.09%
SYMX  SYNTHESIS ENERGY SYS INC$6,700,000
-21.4%
10,000,0000.0%0.09%
-19.5%
DVAX BuyDYNAVAX TECHNOLOGIES CORP$5,352,000
+94.3%
554,600
+19.8%
0.07%
+94.6%
COR SellCORESITE RLTY CORP$5,073,000
-6.4%
49,000
-18.6%
0.07%
-4.2%
CIEIQ NewCOBALT INTL ENERGY INC$5,060,0002,048,595
+100.0%
0.07%
MELI SellMERCADOLIBRE INC$5,018,000
-13.4%
20,000
-27.0%
0.07%
-11.7%
KMDA BuyKAMADA LTD$4,745,000
-4.5%
790,800
+8.2%
0.06%
-3.0%
GRFS NewGRIFOLS S Asp adr rep b nvt$4,157,000196,753
+100.0%
0.06%
WDAY NewWORKDAY INCcl a$3,744,00038,600
+100.0%
0.05%
WBMD SellWEBMD HEALTH CORP$3,794,000
-50.5%
64,688
-55.5%
0.05%
-50.0%
GOOG SellALPHABET INCcap stk cl c$3,635,000
-60.9%
4,000
-64.3%
0.05%
-60.2%
CYH  COMMUNITY HEALTH SYS INC NEWput$3,386,000
+12.3%
340,0000.0%0.05%
+15.0%
BPMC NewBLUEPRINT MEDICINES CORP$3,334,00065,800
+100.0%
0.04%
KTWO BuyK2M GROUP HLDGS INC$2,670,000
+34.9%
109,600
+13.6%
0.04%
+38.5%
SNY SellSANOFIsponsored adr$2,491,000
-63.3%
52,000
-65.3%
0.03%
-62.2%
PBYI BuyPUMA BIOTECHNOLOGY INC$2,404,000
+311.6%
27,500
+75.3%
0.03%
+312.5%
BCRX NewBIOCRYST PHARMACEUTICALS$1,943,000349,500
+100.0%
0.03%
AAPL NewAPPLE INC$1,771,00012,300
+100.0%
0.02%
RIGL BuyRIGEL PHARMACEUTICALS INC$1,807,000
-0.8%
662,056
+20.4%
0.02%0.0%
ENTL NewENTELLUS MED INC$1,701,000102,702
+100.0%
0.02%
IMGN NewIMMUNOGEN INC$1,630,000229,222
+100.0%
0.02%
HALO NewHALOZYME THERAPEUTICS INC$1,424,000111,100
+100.0%
0.02%
RXDX NewIGNYTA INC$1,273,000123,000
+100.0%
0.02%
PODD NewINSULET CORP$1,283,00025,000
+100.0%
0.02%
MULE BuyMULESOFT INCcl a$1,072,000
+120.1%
43,000
+115.0%
0.01%
+133.3%
TRVN  TREVENA INC$938,000
-37.3%
407,6260.0%0.01%
-35.0%
NTLA SellINTELLIA THERAPEUTICS INC$778,000
-29.7%
48,600
-38.2%
0.01%
-26.7%
EDIT  EDITAS MEDICINE INC$839,000
-24.8%
50,0000.0%0.01%
-26.7%
SIEN NewSIENTRA INC$776,00079,800
+100.0%
0.01%
CRSP SellCRISPR THERAPEUTICS AGnamen akt$457,000
-58.4%
28,500
-43.6%
0.01%
-60.0%
TNDM  TANDEM DIABETES CARE INC$400,000
-33.3%
500,0000.0%0.01%
-37.5%
HUN NewHUNTSMAN CORP$336,00013,000
+100.0%
0.01%
ARDMQ  ARADIGM CORP$252,000
-15.7%
192,7270.0%0.00%
-25.0%
OKTA NewOKTA INCcl a added$171,0007,500
+100.0%
0.00%
ARCC ExitARES CAP CORP$0-1
-100.0%
0.00%
OSG ExitOVERSEAS SHIPHOLDING GROUP Icl a new added$0-45,139
-100.0%
-0.00%
CNCE ExitCONCERT PHARMACEUTICALS INC$0-70,229
-100.0%
-0.02%
ALDR ExitALDER BIOPHARMACEUTICALS INC$0-74,000
-100.0%
-0.02%
INSM ExitINSMED INC$0-90,000
-100.0%
-0.02%
SRPT ExitSAREPTA THERAPEUTICS INC$0-78,101
-100.0%
-0.03%
HW ExitHEADWATERS INC$0-100,000
-100.0%
-0.03%
BCRX ExitBIOCRYST PHARMACEUTICALScall$0-350,000
-100.0%
-0.04%
NVDQ ExitNOVADAQ TECHNOLOGIES INCput$0-500,000
-100.0%
-0.05%
BIIB ExitBIOGEN INC$0-17,300
-100.0%
-0.06%
NSR ExitNEUSTAR INCcl a$0-200,000
-100.0%
-0.09%
ETSY ExitETSY INC$0-833,000
-100.0%
-0.12%
FGL ExitFIDELITY & GTY LIFE$0-400,000
-100.0%
-0.15%
PFE ExitPFIZER INC$0-407,500
-100.0%
-0.18%
EBAY ExitEBAY INC$0-471,200
-100.0%
-0.21%
CIE ExitCOBALT INTL ENERGY INC$0-30,944,127
-100.0%
-0.22%
WWAV ExitWHITEWAVE FOODS CO$0-670,000
-100.0%
-0.50%
MJN ExitMEAD JOHNSON NUTRITION CO$0-1,184,200
-100.0%
-1.40%
AKRXQ ExitAKORN INC$0-8,397,100
-100.0%
-2.68%
Other managers

Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):

Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR/A filed 2017-09-20
Signatures

The EDGAR filing(s) were signed by:

About Paulson & Co.

Paulson & Co. is a New York-based investment management firm founded by John Paulson in 1994. The firm is known for its expertise in event-driven investing, which involves taking advantage of market inefficiencies created by corporate events such as mergers, acquisitions, bankruptcies, and spin-offs. Paulson & Co. manages approximately $9 billion in assets and has a team of over 100 professionals.

John Paulson, the founder and CEO of Paulson & Co., is a renowned hedge fund manager who made a fortune by betting against the subprime mortgage market in 2007. He is considered one of the most successful investors of his generation, with a net worth of over $4 billion. Paulson is actively involved in the management of the firm and oversees the investment strategy.

Paulson & Co. has a strong track record of generating high returns for its investors. The firm's flagship fund, the Paulson Advantage Fund, has delivered an average annual return of 12.5% since its inception in 1994. The fund has also outperformed the S&P 500 index in 16 out of the past 22 years.

In recent years, Paulson & Co. has faced some challenges, including a decline in assets under management and a series of high-profile losses. However, the firm has remained committed to its investment philosophy and has continued to generate strong returns for its investors. With a talented team of professionals and a proven track record of success, Paulson & Co. is well-positioned to continue delivering value to its clients in the years ahead.

It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
NOVAGOLD RESOURCES INC42Q3 202312.0%
INTERNATIONAL TOWER HILL MINE42Q3 20233.4%
IAMGOLD CORP42Q3 20230.5%
ANGLOGOLD ASHANTI-SPON ADR41Q2 20237.9%
AGNICO EAGLE MINES LTD34Q3 20233.8%
SPDR GOLD TRUST33Q1 202213.3%
TRILOGY METALS INC NEW29Q3 20230.9%
ENDO INTL PLC28Q2 20223.4%
CAESARS ENTMT CORP27Q4 20194.6%
TIM PARTICIPACOES SA-ADR26Q3 20202.4%

View Paulson & Co.'s complete holdings history.

Latest significant ownerships (13-D/G)
Paulson & Co. Q2 2017 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
Thryv Holdings, Inc.February 14, 20232,000,0005.8%
Endo International plcFebruary 14, 202217,327,0127.4%
BrightSphere Investment Group Inc.December 22, 20218,950,12119.8%
PERPETUA RESOURCES CORP.August 27, 202120,929,28033.3%
Bausch Health Companies Inc.May 15, 202025,839,0357.3%
OVERSEAS SHIPHOLDING GROUP INCApril 13, 20206,300,0007.3%
SYNTHESIS ENERGY SYSTEMS INCFebruary 14, 2020165,64810.5%
Callon Petroleum CoNovember 18, 201910,338,6634.5%
International Seaways, Inc.July 03, 20191,459,1195.0%
AKORN INCSold outFebruary 14, 201800.0%

View Paulson & Co.'s complete significant-ownership history.

Latest filings
TypeFiled
13F-HR2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
42024-01-22
SC 13D/A2024-01-22
13F-HR2023-11-14
SC 13G2023-11-13
13F-HR2023-08-14
13F-HR2023-05-15
13F-HR2023-02-14

View Paulson & Co.'s complete filings history.

Compare quarters

Issues

The following issues were detected while analyzing the report:

  • The reported has been restated
  • The reported has been amended

Export Paulson & Co.'s holdings